Literature DB >> 26433702

Simplified 2-tier histologic grading system accurately predicts outcomes in goblet cell carcinoid of the appendix.

Lawrence H Lee1, Yarrow J McConnell2, Erica Tsang3, Siham Zerhouni4, Caroline Speers5, Hagen Kennecke3, David F Schaeffer6.   

Abstract

Goblet cell carcinoid (GCC) is a rare appendiceal malignancy with both neuroendocrine and glandular features. Clinical outcomes of patients with GCC vary widely and a histology-based 3-tiered prognostic scheme has been previously suggested; however, this scheme is subjective and challenging to apply in day-to-day practice. We sought to construct a simplified and prognostic grading system based on objective histologic features with specific criteria. A continuous population-based cohort of GCC with clinical outcome data and archival tissue available for review was extracted from regional databases. For the 78 patients with confirmed appendiceal GCC, specific histologic features, including cytologic atypia, peritumoral stromal desmoplasia, and solid growth pattern, were recorded, and a scoring system was devised, which separates patients with GCC into low-grade (n = 55; 71%) or high-grade (n = 23; 29%) histology. Correspondingly, clinical follow-up data show good prognosis in those with low-grade histology with median and 10-year overall survival of 51.0 months and 80.5%, respectively, whereas those with high-grade histology have a poor prognosis with median and 10-year overall survival of 16.5 months (P = .006) and 0% (P < .001), respectively. Multivariate Cox proportional hazard modeling demonstrates that this 2-tier histologic system remains predictive of overall survival when controlled for TNM clinicopathological stage. These data show that a simple and objective histologic scoring system separates GCC into low- and high-grade histology with divergent clinical outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoid; Adenoneuroendocrine; Crypt cell carcinoma; Goblet cell carcinoid; Histopathologic grading; Mixed adenoneuroendocrine carcinoma

Mesh:

Year:  2015        PMID: 26433702     DOI: 10.1016/j.humpath.2015.08.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

Review 1.  New insights in the pathology of peritoneal surface malignancy.

Authors:  Norman John Carr
Journal:  J Gastrointest Oncol       Date:  2021-04

2.  Incidental discovery of goblet cell carcinoid, a rare appendiceal malignancy case report.

Authors:  Daniel Barbash; Aakash A Trivedi; James Y Yang; Richard B Nguyen; John C Huribal; Jamshed Zuberi; Osama Elsawy; Scott Wessner
Journal:  J Surg Case Rep       Date:  2022-07-31

3.  Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry.

Authors:  Kieran Palmer; Scott Weerasuriya; Kandiah Chandrakumaran; Brian Rous; Benjamin E White; Sangeeta Paisey; Rajaventhan Srirajaskanthan; John K Ramage
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

4.  Goblet cell carcinoid of the appendix: Two case reports and a review of the literature.

Authors:  Alejandro Livoff; Noam Asna; Enrique Gallego-Colon; Aner Zeev Daum; Tattiana Harkovsky; Moshe Schaffer
Journal:  Mol Clin Oncol       Date:  2019-09-11

5.  Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity.

Authors:  Dan Huang; Fei Ren; Shujuan Ni; Cong Tan; Weiwei Weng; Meng Zhang; Midie Xu; Lei Wang; Qinghua Xu; Weiqi Sheng
Journal:  Cancer Cell Int       Date:  2019-11-21       Impact factor: 5.722

6.  Duodenal Obstruction Caused by the Long-term Recurrence of Appendiceal Goblet Cell Carcinoid.

Authors:  Masashi Saito; Kiyotaka Asanuma; Waku Hatta; Tomoyuki Koike; Tatsuo Hata; Fumiyoshi Fujishima; Toru Furukawa; Michiaki Unno; Atsushi Masamune
Journal:  Intern Med       Date:  2020-08-04       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.